Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system
No. | 24 |
---|---|
Citation | Thromb Haemost 117(01),p75-85(2017) |
Institute | Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden |
1st Author | A Ågren |
AR | ○ |
PL | ○ |
HD | |
Paper types | Clinical investigations |
Main purpose | Drug efficacy evaluation |
Disease | VWD type3 |
Antiplatelet drug | |
Anticoagulant drug | |
Other drug | |
Clinical specimens | |
Animal | |
Keyword |